Research Article Volume 22 Issue 8 - 2026

Virtual Colony Count Study of the Inoculum Effect of HNP1 against Staphylococcus aureus ATCC 29213

Bryan Ericksen*

School of Medicine Institute of Human Virology, University of Maryland, Baltimore, Baltimore, Maryland, USA

*Corresponding Author: Bryan Ericksen, School of Medicine Institute of Human Virology, University of Maryland, Baltimore, Baltimore, Maryland, USA.
Received: July 30, 2026; Published: August 13, 2026



Background: Virtual colony count is a kinetic, 96-well turbidimetric assay that has been used since 2003 to determine the antimicrobial activity of antimicrobial peptides including the defensin HNP1. Virtual colony count results differed from traditional colony counting results in studies of the antimicrobial activity of the human cathelicidin LL-37 and related peptides. The difference could possibly have been caused by an inoculum effect.

Methods: The virtual colony count assay was conducted using inocula that varied from 1250 to 1x108 virtual colony forming units (CFUv) per milliliter.

Results: The virtual colony count assay demonstrated a pronounced inoculum effect of HNP1 against Staphylococcus aureus ATCC 29213, accompanied by biofilm formation observed in the wells of the 96 well plates at all inocula. The S. aureus inoculum effect was not as drastic as previously reported for Escherichia coli.

Conclusion: The inoculum effect is further evidence that biofilm formation is a resistance mechanism used by a variety of bacteria against antimicrobial peptides such as HNP1.

Keywords: HNP1; Staphylococcus aureus ATCC 29213; Virtual Colony Count (VCC)

  1. Ericksen B., et al. “Antibacterial activity and specificity of the six human α-defensins”. Antimicrobial Agents and Chemotherapy 1 (2005): 269-275.
  2. Pazgier M., et al. “Sometimes it takes two to tango: contributions of dimerization to functions of human α-defensin HNP1 peptide”. Journal of Biological Chemistry 12 (2012): 8944-8953.
  3. Rajabi M., et al. “Functional determinants of human enteric α-defensin HD5: crucial role for hydrophobicity at dimer interface”. Journal of Biological Chemistry26 (2012): 21615-21627.
  4. Wei G., et al. “Through the looking glass, mechanistic insights from enantiomeric human defensins”. Journal of Biological Chemistry 42 (2009): 29180-29192.
  5. Wei G., et al. “Trp-26 imparts functional versatility to human alpha-defensin HNP1”. Journal of Biological Chemistry 21 (2010): 16275-16285.
  6. Wu Z., et al. “Why is the Arg5-Glu13 salt bridge conserved in mammalian alpha-defensins?” Journal of Biological Chemistry 52 (2005): 43039-43047.
  7. Wu Z., et al. “Impact of pro segments on the folding and function of human neutrophil alpha-defensins”. Journal of Molecular Biology 2 (2007): 537-549.
  8. Xie C., et al. “Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids”. Journal of Biological Chemistry 38 (2005): 32921-32929.
  9. Xie C., et al. “Effects of the terminal charges in human neutrophil alpha-defensin 2 on its bactericidal and membrane activity”. Peptides 12 (2005): 2377-2383.
  10. Zhao L., et al. “Invariant gly residue is important for α-defensin folding, dimerization, and function: a case study of the human neutrophil α-defensin HNP1”. Journal of Biological Chemistry 23 (2012): 18900-18912.
  11. Zhao L., et al. “Single, double and quadruple alanine substitutions at oligomeric interfaces identify hydrophobicity as the key determinant of human neutrophil alpha defensin HNP1 function”. PLoS One 11 (2013): e78937.
  12. Zou G., et al. “Molecular determinants for the interaction of human neutrophil alpha defensin 1 with its propeptide”. Journal of Molecular Biology 5 (2008): 1281-1291.
  13. Pazgier M., et al. “Structural and functional analysis of the pro-domain of human cathelicidin LL-37”. Biochemistry9 (2013): 1547-1558.
  14. Brook I. “Inoculum effect”. Reviews of Infectious Diseases 3 (1989): 361-368.
  15. Ericksen B., et al. “Virtual colony count”. WikiJSci1 (2020): 3.
  16. Liao C., et al. “Human neutrophil α-defensin HNP1 interacts with bacterial cell wall components to promote biofilm formation by Staphylococcus aureus”. Biofilm 10 (2025): 100338.
  17. Alcouloumre MS., et al. “Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro”. Antimicrobial Agents and Chemotherapy 12 (1993): 2628-2632.
  18. Rubinchik E., et al. “Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonization models”. International Journal of Antimicrobial Agents 5 (2009): 457-461.
  19. McDonnell MJ., et al. “Inhibition of verocytotoxigenic Escherichia coli by antimicrobial peptides caseicin A and B and the factors affecting their antimicrobial activities”. International Journal of Food Microbiology 3 (2012): 260-268.
  20. Snoussi M., et al. “Heterogeneous absorption of antimicrobial peptide LL-37 in Escherichia coli cells enhances population survivability”. eLife 7 (2018): e38174.
  21. Loffredo MR., et al. “Inoculum effect of antimicrobial peptides”. Proceedings of the National Academy of Sciences of the United States of America 21 (2021): e2014364118.
  22. Ikuma K., et al. “The extracellular bastions of bacteria-a biofilm way of life”. Nature Education Knowledge 2 (2013): 2.
  23. Ericksen B. “Quantification of polysaccharides fixed to Gram stained slides using lactophenol cotton blue and digital image processing”. F1000Research 4 (2015): 1.

Bryan Ericksen. “Virtual Colony Count Study of the Inoculum Effect of HNP1 against Staphylococcus aureus ATCC 29213”. EC Microbiology 22.9 (2026): 01-06.